Method of implanting and using a subcutaneous defibrillator

• US 8,577,454 B2
• Filed: 11/01/2011
• Issued: 11/05/2013
• Est. Priority Date: 09/18/2000
• Status: Expired due to Fees

• Current Assignee: Cameron Incorporated (Schlumberger NV)
• Original Assignee: Cameron Incorporated (Schlumberger NV)
• Inventors: Bardy, Gust H., Cappato, Riccardo
• Primary Examiner(s): Gedeon, Brian T
• Application Number:
  US13/286,673
• Publication Number:
  US 20120046705A1
• Time in Patent Office: 735 Days
• Field of Search: 607/2, 607/4, 607/5, 607 33- 38, 607/119, 128/898
• US Class Current: 607/5
• CPC Class Codes: A61B 5/283 Invasive
• CPC Class Codes: A61B 5/29 for permanent or long-term implantation
• CPC Class Codes: A61N 1/36521 the parameter being derived from measurement of an electrical impedance
• CPC Class Codes: A61N 1/375 Constructional arrangements, e.g. casings
• CPC Class Codes: A61N 1/37512 Pacemakers
• CPC Class Codes: A61N 1/3756 Casings with electrodes thereon, e.g. leadless stimulators
• CPC Class Codes: A61N 1/3906 characterised by the form of the shockwave
• CPC Class Codes: A61N 1/3956 Implantable devices for applying electric shocks to the heart, e.g. for cardioversion

Abstract

A subcutaneous implantable cardioverter-defibrillator is disclosed which has an electrically active canister which houses a source of electrical energy, a capacitor, and operational circuitry that senses the presence of potentially fatal heart rhythms. At least one subcutaneous electrode that serves as the opposite electrode from the canister is attached to the canister via a lead system. Cardioversion-defibrillation energy is delivered when the operational circuitry senses a potentially fatal heart rhythm. There are no transvenous, intracardiac, or epicardial electrodes. A method of subcutaneously implanting the cardioverter-defibrillator is also disclosed as well as a kit for conducting the method.

Claims

1. A method of treating a patient comprising:

implanting a defibrillator system in the patient including a canister containing operational circuitry for operating the defibrillator system and a lead, the canister and lead each including at least one electrode for use in sensing of cardiac activity and/or therapy delivery, wherein;

the lead includes a first end for attachment to the canister and a second end having an anchoring system;

the lead is implanted with numerous waves or bends;

the lead and canister are implanted subcutaneously on the thorax of the patient over the ribcage of the patient without any part of the defibrillator system entering the patient'"'"'s vasculature or touching the patient'"'"'s heart; and

the patient is expected to grow and the implantation is performed such that as the patient grows, the waves or bends of the lead will straighten out to maintain proper electrode placement; and

the defibrillator system detecting ventricular tachycardia or fibrillation by examining QRS waves of the patient and determining whether the patient'"'"'s cardiac activity includes a ventricular rate that exceeds a predetermined rate for a first fixed period of time and, if so, the defibrillator system charging a capacitor for therapy delivery and, once the capacitor is charged, the defibrillator system performing a confirmatory rhythm check before discharging the capacitor for therapy delivery, therapy delivery utilizing an electrode of the canister and an electrode of the lead.

2. The method of claim 1 further comprising the defibrillator system detecting respiration by observing undulations of transthoracic impedance and, if no undulations are detected, confirming that cardiac arrest is occurring.

3. The method of claim 2 wherein the canister comprises a conductive surface and at least one sensing electrode isolated from the conductive surface by an insulating structure, wherein the conductive surface is used as the electrode of the canister for therapy delivery, and the sensing electrode is used for sensing QRS waves.

4. The method of claim 2 wherein the defibrillator system detects respiration by delivering subthreshold currents transthoracically using subcutaneously placed electrodes.

5. The method of claim 1 wherein the canister comprises a conductive surface and at least one sensing electrode isolated from the conductive surface by an insulating structure, wherein the conductive surface is used as the electrode of the canister for therapy delivery, and the sensing electrode is used for sensing QRS waves.

6. The method of claim 1 wherein:

the predetermined rate is 240 beats per minute and the first period of time is 4 seconds; and

the confirmatory rhythm check includes determining whether the ventricular rate exceeds the predetermined rate level for at least a second period of time, wherein the second period of time is 1 second.

7. The method of claim 1 wherein the anchoring structure is a tine.

8. The method of claim 1 wherein the anchoring structure is a screw.

9. The method of claim 1 wherein the anchoring structure is a hook.

10. The method of claim 1 wherein the anchoring structure is a suture.

11. The method of claim 1 wherein the step of implanting is performed such that the canister is placed at approximately the left inframammary crease of the patient and the lead extends around the thorax of the patient from the canister.